STAT

JUNE 5, 2025

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications. The research, published Thursday in JAMA Ophthalmology , found that after one year, more than twice as many people on GLP-1 drugs developed neovascular age-related macular degeneration compared to similar people who were no

Diabetes 281

Diabetes Drug Development 281

PharmaVoice

JUNE 5, 2025

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

260

260

STAT

JUNE 5, 2025

In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly obesity treatment that targeted three hormones at once. In mice studies , the drug, which activated receptors of the GLP-1, GIP, and glucagon hormones, caused notable weight loss. But Novo shelved the therapy. The company was concerned about potential side effects of targeting glucagon, like increasing blood sugar and heart rate.

Drug Development 258

Drug Development 258

pharmaphorum

JUNE 5, 2025

Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people"

101

101

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

JUNE 5, 2025

Global health threats don’t respect borders — they require strong collaborations and trust across partners. Yet a  new policy  from the National Institutes of Health blindsided U.S. researchers and could immediately upend the international research collaborations critical for understanding and responding to global health threats.

181

181

STAT

JUNE 5, 2025

Vijay Yadav warned people not to start downing taurine — an amino acid abundant in plants, animals and some energy drinks — just because his mice and monkey study suggested it might be an elixir for long life. But that doesn’t mean they listened. “The other day, I was talking to I think the scientific director of one of the largest pharma in the U.S., he was taking 14 grams of taurine per day,” said Yadav, or roughly 14 Red Bulls’ worth.

219

219

BioPharma Dive

JUNE 5, 2025

A deal worth up to $712 million with the China-based biotech gives Cullinan T cell engagers aimed at BCMA and CD19, two targets of interest in inflammatory conditions.

95

95

STAT

JUNE 5, 2025

On this week’s episode of “The Readout LOUD”: The Food and Drug Administration’s AI adventure, a deep look inside Novo Nordisk’s obesity stumble, and finally, another big M&A deal in biotech. The FDA has rolled out an internal AI tool called Elsa that, unlike its namesake Disney character, can’t seem to let go of mistakes.

147

147

pharmaphorum

JUNE 5, 2025

Novo Nordisk's long-acting injectable Sogroya has been backed for NHS use in young people with growth hormone deficiency

104

104

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

JUNE 5, 2025

New funding supports development of diagnostic platform

94

94

Express Pharma

JUNE 5, 2025

The Authentication Solution Providers’ Association (ASPA) has announced the commissioning of the second edition of its industry report titled State of Counterfeiting in India – 2025 , in collaboration with global analytics company CRISIL. The announcement was made ahead of World Anti-Counterfeiting Day, which is observed to raise awareness about the global impact of counterfeit goods.

Documentation 52

Documentation 52

Putting Patients First Blog

JUNE 5, 2025

Guest Blog: From Eye Patches to Indie Films: How Pop Culture Can Spark Conversations About Children’s Vision Health June 5, 2025 By: Jeff Todd, President & CEO, Prevent Blindness We know that pop culture can shape public conversations. Memes and headlines spark cultural touchpoints and can make complex health topics more relatable. A fictional character’s health-related experience on screen sparks questions about the reality of diseases like cancer or chronic health conditions such as diabe

Diabetes 52

Diabetes 52

pharmaphorum

JUNE 5, 2025

Women in the UK taking weight-loss injections have been warned by the MHRA that they should make sure they are using effective contraception

82

82

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

World Pharma News

JUNE 5, 2025

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing multiple myeloma, the second most common type of blood cancer. The study showed that the diet was not only feasible and well-received but also improved several factors that could potentially delay the progression of precancerous conditions that can lead to multiple myeloma.

74

74

Express Pharma

JUNE 5, 2025

Brazil generates power from a diverse range of sources that include thermal sources (gas, oil, and coal), hydropower, nuclear, and renewable. Hydropower accounts for the majority of the country’s annual power generation. However, overdependence on hydropower has made the country vulnerable to droughts. To overcome the challenge, the country is rapidly developing its renewable power capacity.

77

77

pharmaphorum

JUNE 5, 2025

A new way to deliver mRNA to T cells could allow HIV that is hiding away to be exposed and targeted with antiretroviral therapies, say scientists

93

93

Pharmaceutical Commerce

JUNE 5, 2025

In the first part of her Pharma Commerce video interview, Maggie McCullough, PolicyMaps CEO, explains how geospatial mapping can help identify and address emerging pharmacy deserts across the United States.

59

59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmaceutical Technology

JUNE 5, 2025

Chinas NMPA has approved Akeso's PD-1/CTLA-4 bispecific antibody, cadonilimab, to treat persistent, recurrent or metastatic cervical cancer.

52

52

pharmaphorum

JUNE 5, 2025

With new guidance, the EMA is seeking to ramp up the inclusion of pregnant and breastfeeding women in clinical trials

69

69

Pharmaceutical Technology

JUNE 5, 2025

Regeneron and Sanofis blockbuster Dupixent has transformed the atopic dermatitis market, with future disruptors in the pipeline.

52

52

Drug Patent Watch

JUNE 5, 2025

"The Patent Expiration Effect: How Big Pharma's Weak Spots Become Your Next Big Score When a pharmaceutical giant's patent expires, it's like throwing a lifeline to savvy investors. The waters are chock-full of opportunities to capitalize on the disruption. In our latest report, we dive into the world of patent expirations and reveal the top targets for predatory investment.

61

61

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

JUNE 5, 2025

Vividion Therapeutics has secured worldwide rights for developing and commercialising VVD-214, the Werner helicase (WRN) covalent inhibitor.

52

52

pharmaphorum

JUNE 5, 2025

A new auction for bankrupt genetic testing company 23andMe looks likely after former CEO Anne Wojcicki offered to outbid Regeneron

59

59

The Pharmacist

JUNE 5, 2025

Community pharmacies dispensed 1.26 billion prescription items in England in 2024/2025 a 4% increase from 1.21 billion in the previous year. The cost of prescription items dispensed in the community in England was 11.2bn and a 2% increase from 10.9bn in 2023/24, according to a new report from the NHS Business Services Authority (NHSBSA). […] The post 4% rise in prescription items dispensed by pharmacies appeared first on The Pharmacist.

Community Pharmacies 59

Community Pharmacies 59

Express Pharma

JUNE 5, 2025

Alvotech, a global biotech company focused on the development and manufacture of biosimilar medicines, and Dr Reddys Laboratories, including its subsidiaries, have announced a collaboration and license agreement to co-develop, manufacture, and commercialise a biosimilar candidate to Keytruda (pembrolizumab) for global markets. Keytruda (pembrolizumab) is approved for the treatment of multiple cancer types.

Biosimilars 59

Biosimilars 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.